由于美托克洛普拉米德过量服用而导致的长期外皮拉米德综合征:一个罕见的病例报告
Abdollah Malakian1, Alireza Omrani2, Arshia Omrani2
1Department of Emergency Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, 48166-33131, Iran.
Oxford medical case reports
|February 24, 2025
概括
甲托克洛普拉米德过量服用可能会导致有关非皮拉米德的副作用,如 dystonia. 及时诊断和适当的治疗对于患者的康复和减少家庭焦虑至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 紧急医疗 紧急医疗
背景情况:
- 梅托克洛普拉米德是一种常见的抗药,用于紧急情况.
- 外皮拉米德的副作用是已知的,尽管令人担忧的,使用美托克洛普拉米德的并发症.
- 高剂量摄入可以加速这些不良反应.
研究的目的:
- 在青少年中报告甲托克洛普拉米德诱导的部 dystonia 的病例.
- 突出潜在的误诊和延迟治疗额外金字塔综合征.
- 强调适当监测和管理美托克洛普拉米德副作用的重要性.
主要方法:
- 一个18岁的女学生的案例报告,无意中服用了美托克洛普拉米德过量 (60毫克).
- 临床表现包括部 dystonia 和向上眼睛偏差摄入后六小时.
- 当地医疗中心对biperiden的初始治疗无效,导致转诊医院.
主要成果:
- 患者在甲托克洛普拉米德过量服用后出现了急性部 dystonia 和 oculogyric 危机.
- 使用biperiden的标准治疗并没有解决症状.
- 这一案例强调了诊断和管理由美托克洛普拉米德诱导的超金字塔反应所面临的挑战.
结论:
- 对美托克洛普拉米德的 dystonic 反应可能是严重的,并且可能被误诊.
- 有效的管理需要及时识别和适当的治疗干预.
- 密切监测至关重要,以减轻与这些副作用相关的患者和家庭痛苦.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
234
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
234
Parkinson's Disease: Treatment
185
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
185
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
212
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
212
Anticholinesterase Agents: Poisoning and Treatment
773
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
773
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
70
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
70
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K


